Are you the publisher? Claim or contact us about this channel


Embed this content in your HTML

Search

Report adult content:

click to rate:

Account: (login)

More Channels


Showcase


Channel Catalog


Channel Description:

Daily news and press releases about Healthcare

older | 1 | .... | 1114 | 1115 | (Page 1116) | 1117 | 1118 | .... | 1146 | newer

    0 0

    (EMAILWIRE.COM, December 14, 2018 ) Know in detail regarding the global Orthopedic Trauma Devices marketing research, Forecasts, and overview and Market Development

    "Global Orthopedic Trauma Devices market Analysis to 2025" is a specialized and in-depth study of the Orthopedic Trauma Devices industry with a focus on the global market trend. The report aims to provide an overview of global Orthopedic Trauma Devices market with detailed market segmentation by component, type, application and geography. The global Orthopedic Trauma Devices market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.



    Get PDF sample Copy @ https://www.theinsightpartners.com/sample/TIPHE100001389/?nb





    The Report Provides A Detailed Overview Of The Industry Including Both Qualitative And Quantitative Data. It Provides Summary And Forecast Of The World Leading Orthopedic Trauma Devices Market Supported Product And Application. It Also Provides Market Size And Forecast Till 2025 For Overall Orthopedic Trauma Devices Market With Regard To 5 Major Regions, Namely; North America, Europe, Asia-Pacific (Apac), Middle East And Africa (Mea) And South America (Sam), Which Is Later Sub-Segmented By Various Countries And Segments. The Report Evaluates Market Dynamics Effecting The Market During The Forecast Period I.E., Drivers, Restraints, Opportunities, And Future Trend And Provides Exhaustive Pest Analysis For All 5 Regions.

    An Exclusive Orthopedic Trauma Devices Market Analysis Report Created Through Broad Primary Research (Inputs From Industry Specialists, Companies, And Stakeholders) And Secondary Research, The Report Aims To Present The Analysis Of Global Orthopedic Trauma Devices Market By Type, By Application, By Region - North America, Europe, South America, Asia-Pacific, Middle East And Africa. The Report Intends To Provide Cutting-Edge Market Intelligence And Help Decision Makers Take Sound Investment Evaluation. Besides, The Report Conjointly Identifies And Analyses The Rising Trends Alongside Major Drivers, Challenges And Opportunities Within The International Orthopedic Trauma Devices Market. Additionally, the Report Also Highlights Market.



    Also, Key Orthopedic Trauma Devices Market Players Influencing the Market Are Profiled within the Study Along With Their swot Analysis and Market Ways. The Report Also Focuses On Leading Industry Players With Data Like Company Profiles, Products And Services Offered, Financial Information Of Last Three Years, and Key Development In Past 5 Years.





    Inquire for Further Detailed Information @ https://www.theinsightpartners.com/discount/TIPHE100001389/?nb



    Reason to Buy

    · Save And Reduce Time Carrying Out Entry-Level Analysis By Identifying The Growth, Size, Leading Players And Segments Within The Global Orthopedic Trauma Devices Market

    · Highlights Key Business Priorities in Order to Help Companies to Realign Their Business Strategies.

    · The Key Findings And Recommendations Highlight Crucial Progressive Business Trends Within The Orthopedic Trauma Devices Market, Thereby Allowing Players To Develop Effective Long Term Strategies.

    · Develop/Modify Business Growth Plans By Using Substantial Growth Providing Developed And Emerging Markets.

    · Scrutinize In-Depth Global Market Trends And Outlook Coupled With The Factors Driving The Market, Similarly As Those Hindering It.

    · Enhance The Decision-Making Process By Understanding The Strategies That Underpin Commercial Interest With Respect To Product, Segmentation And Industry Verticals.



    About Us

    The Insight Partners Is A One Stop Industry Research Provider Of Actionable Intelligence. We Help Our Clients In Getting Solutions To Their Research Requirements Through Our Syndicated And Consulting Research Services.

    We Are Committed To Providing Highest Quality Research And Consulting Services To Our Customers. We Help Our Clients Understand Key Market Trends, Identify Opportunities, And Make Informed Decisions By Providing Market Research Solutions At An Affordable Cost.


    Sameer Joshi
    +1-646-491-9876
    sam@theinsightpartners.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, December 14, 2018 ) New Analysis Report Provides Key Statistics On The Market Standing Of The Key Players And Offers Key Trends And Opportunities In The Market.

    "Global Sepsis Diagnostics Market Analysis to 2025" is a specialized and in-depth study of the Sepsis Diagnostics industry with a focus on the global market trend. The report aims to provide an overview of global Sepsis Diagnostics market with detailed market segmentation by component, type, application and geography. The global Sepsis Diagnostics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.



    Get PDF sample Copy @ https://www.theinsightpartners.com/sample/TIPHE100001391/?nb





    The Report Provides A Detailed Overview Of The Industry Including Both Qualitative And Quantitative Data. It Provides Summary And Forecast Of The World Leading Sepsis Diagnostics Market Supported Product And Application. It Also Provides Market Size And Forecast Till 2025 For Overall Sepsis Diagnostics Market With Regard To 5 Major Regions, Namely; North America, Europe, Asia-Pacific (Apac), Middle East And Africa (Mea) And South America (Sam), Which Is Later Sub-Segmented By Various Countries And Segments. The Report Evaluates Market Dynamics Effecting The Market During The Forecast Period I.E., Drivers, Restraints, Opportunities, And Future Trend And Provides Exhaustive Pest Analysis For All 5 Regions.

    Sepsis is a systemic inflammatory response against the microbial infections, which can lead to organ dysfunction or failure. It is possible by pathogenic micro-organisms including bacterial, viral, fungal or parasitic organism that can easily enter the bloodstream. As a result, they can arise infection at a localized site of infection such as the lung or urogenital tract. On the other hand, the entry of microorganism in the blood stream is also possible via skin-breaks and also caused by surgery or the insertion of catheters during hospital treatment. In turn, systemic immune response take place that can cause severe symptoms including elevated heart rate and rapid breathing or severe fever. It is a potentially lethal condition that can leads directly to the death. In order to identify of causative agent, sepsis Diagnostics is performed. Sepsis occurs in a condition, when an immune system of the host responds to an infection, and then chemicals released to treat the infection.

    The market for sepsis Diagnostics is expected to grow significantly in the coming years, owing to the key factors such as high incidence of hospital-acquired infections, increasing government initiatives for creating sepsis awareness and rising geriatric population across the globe. Moreover, increasing adoption of high-end sepsis diagnostics devices, increasing health care awareness and health care expenditure are likely to add novel opportunities for the global sepsis Diagnostics market over the forecast period.



    Inquire for Further Detailed Information @ https://www.theinsightpartners.com/discount/TIPHE100001391/?nb



    North America is expected to dominate the sepsis Diagnostics market in the global arena due to growing adoption of new and advanced diagnostic techniques, and increasing incidences of chronic diseases such as cancer or/and diabetes leading to increasing hospital admissions. However, the Asia-Pacific region is anticipated to show a significant growth rate over the next few years in the global sepsis Diagnostics market due to rising incidences of hospital acquired infections in the region.


    The sepsis Diagnostics market report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.

    The sepsis Diagnostics market report also includes the profiles of sepsis Diagnostics manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the sepsis Diagnostics market are Danaher, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., bioMérieux SA, T2 Biosystems, Inc., BD, Abbott, Luminex Corporation, Immunexpress, Axis-Shield Diagnostics Ltd. and among others.


    Sameer Joshi
    +1-646-491-9876
    sam@theinsightpartners.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 14, 2018 ) New Analysis Report Provides Key Statistics On The Market Standing Of The Key Players And Offers Key Trends And Opportunities In The Market.

    The "Global Artificial Joints Market Analysis to 2025" is a specialized and in-depth study of the medical device industry with a focus on the global market trend. The report aims to provide an overview of global artificial joints market with detailed market segmentation by type, material, application, end user, and geography. The global artificial joints market is expected to witness high growth during the forecast period. The artificial joints market report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.

    Get PDF sample Copy @ https://www.theinsightpartners.com/sample/TIPHE100001392/?nb





    Joint replacement is one of the most popular orthopedic procedures undergone by the patients suffering from severe joint pains or dysfunction in surgical centers and hospitals. Osteoarthritis, rheumatoid arthritis or post-traumatic arthritis are the key indications for joint replacement. Artificial joints are used in joint replacement procedure to replace the damaged or disease joints. These products are made up of various materials such as ceramics and alloys.

    The growth of artificial joints market is attributed rising geriatric population, ever increasing prevalence of orthopedic diseases such as osteoarthritis and growing popularity of joint replacement surgery. New product launches by market players and technology development in orthopedic sector are anticipated to offer growth opportunities during the forecast period.


    The global artificial joints market is segmented on the basis of type, material, application, and end user. Based on type, the market is segmented into cemented joints and non-cemented joints. On the basis of material, the market is segmented into ceramics, alloys, oxinium, and others. On the basis of application, the market is segmented into artificial joints of knee, artificial joints of hip, artificial joints of shoulder, and others. On the basis of end user, the market is segmented into hospitals, ambulatory surgical centers and others.

    The artificial joints market report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global artificial joints market based on type, material, application, and end user. It also provides market size and forecast till 2025 for overall artificial joints market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.

    Inquire for Further Detailed Information @ https://www.theinsightpartners.com/discount/TIPHE100001392/?nb



    In North America, US is expected to hold a significant share in the artificial joints followed by Canada. Key factors driving the market growth are extensive research and development activities for the development of new products and growing number of manufacturers and distributors of orthopedic products in these countries. Asia Pacific is expected to grow exponentially in coming years for artificial joints. The exponential growth of orthopedic procedures and high prevalence of osteoarthritis are the major factors is expected to drive the growth of this market during the forecast period.

    The artificial joints market report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.

    The artificial joints market report also includes the profiles of key artificial joints manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the artificial joints market are Zimmer Biomet, DePuy Synthes, Smith & Nephew, Stryker, Medtronic, Exactech, Inc., B. Braun Melsungen AG, JRI Orthopaedics Limited, DJO, LLC, SAMO and others.


    Sameer Joshi
    +1-646-491-9876
    sam@theinsightpartners.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, December 14, 2018 ) Global Cannabis Testing Market Report Covers Analysis of Manufacturers, Type, Application, Marketing Strategy, Distributors/Traders, Effect Factors, Trends 2019 & Forecasts 2025.

    "Global Cannabis Testing Market Analysis to 2025" is a specialized and in-depth study of the Cannabis Testing industry with a focus on the global market trend. The report aims to provide an overview of global Cannabis Testing market with detailed market segmentation by component, type, application and geography. The global Cannabis Testing market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.



    Get PDF sample Copy @ https://www.theinsightpartners.com/sample/TIPHE100001394/?nb





    The Report Provides A Detailed Overview Of The Industry Including Both Qualitative And Quantitative Data. It Provides Summary And Forecast Of The World Leading Cannabis Testing Market Supported Product And Application. It Also Provides Market Size And Forecast Till 2025 For Overall Cannabis Testing Market With Regard To 5 Major Regions, Namely; North America, Europe, Asia-Pacific (Apac), Middle East And Africa (Mea) And South America (Sam), Which Is Later Sub-Segmented By Various Countries And Segments. The Report Evaluates Market Dynamics Effecting The Market During The Forecast Period I.E., Drivers, Restraints, Opportunities, And Future Trend And Provides Exhaustive Pest Analysis For All 5 Regions.

    Cannabis testing is used in variety of applications that includes determining the concentration of cannabis in various analytical samples such as pharmaceutical drugs, and detection of contaminants such as bacteria and fungi. Furthermore, the cannabis testing is also performed for determination of trace metals such as arsenic, cadmium that can adversely impact health if remained unchecked. These tests are performed with the help of various analytical techniques that include chromatography analysis, spectrometry, ELISA, polymerase chain reaction (PCR) and others.

    The growth of global cannabis testing market is expected to be driven by various factors such as legalization of cannabis for recreational and medicinal purposes and increasing approval of cannabis for medicinal purposes. Moreover, the new laws on compulsory testing of cannabis for recreational use is also expected to propel the market growth. On the other hand, low investments in research and development, stringent regulatory framework, and high infrastructure cost of cannabis testing set up are going to hamper the market growth at certain extent during the forecast period.

    North America holds a dominant position in the global cannabis testing market. This is primarily attributed to well-established healthcare infrastructure in the region and rising number of states in the US legalizing the use of cannabis for medicinal purposes. For instance, the Attorney General of the Obama-Era Guidelines in March 2018 reported that nine states in the US and the District of Columbia has legalized recreational use of Marijuana whereas additional 21 states allow the use of Cannabis only for medicinal purposes. Several other factors such as rise in number of laboratories for testing cannabis and presence of leading market players are also responsible for North America to hold a dominant position in the global cannabis testing market. Asia Pacific on the other hand is expected to witness significant growth over the forecast years owing to increasing healthcare expenditure allotted by the governments of the developing economies of this region.





    Inquire for Further Detailed Information @ https://www.theinsightpartners.com/discount/TIPHE100001394/?nb





    The cannabis testing market report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The cannabis testing market report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.

    The cannabis testing market report also includes the profiles of leading players involved in cannabis testing equipment manufacturing and service providing along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key developments in past five years. Some of the prominent players operating in the global cannabis testing market include Agilent Technologies, PerkinElmer, Inc., Shimadzu Corporation, SCIEX, Merck KGaA, Restek Corporation, Waters, CannaSafe Analytics, Accelerated Technology Laboratories, Inc., and Digipath Labs.


    Sameer Joshi
    +1-646-491-9876
    sam@theinsightpartners.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, December 14, 2018 ) The Insight Partners added “Global Intracranial Stents Market Research Report 2025” to its vast assortment of research database. The report is spread across 124 pages and supported by2 4 company leaders.

    "Global Intracranial Stents Market Analysis to 2025" is a specialized and in-depth study of the Intracranial Stents industry with a focus on the global market trend. The report aims to provide an overview of global Intracranial Stents market with detailed market segmentation by component, type, application and geography. The global Intracranial Stents market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.



    Get PDF sample Copy @ https://www.theinsightpartners.com/sample/TIPHE100001398/?nb





    The Report Provides A Detailed Overview Of The Industry Including Both Qualitative And Quantitative Data. It Provides Summary And Forecast Of The World Leading Intracranial Stents Market Supported Product And Application. It Also Provides Market Size And Forecast Till 2025 For Overall Intracranial Stents Market With Regard To 5 Major Regions, Namely; North America, Europe, Asia-Pacific (Apac), Middle East And Africa (Mea) And South America (Sam), Which Is Later Sub-Segmented By Various Countries And Segments. The Report Evaluates Market Dynamics Effecting The Market During The Forecast Period I.E., Drivers, Restraints, Opportunities, And Future Trend And Provides Exhaustive Pest Analysis For All 5 Regions.

    Intracranial stents also known as brain stents are devices implanted into the brains of patients that possess high risk conditions of the brain arteries. These stents help to open up the blocked arteries in the brain among patients suffering with diseases such as intracranial stenosis. The implantation of intracranial stents is a relatively new procedure and the results for long-term placement of these stents are still under investigational studies. A number of studies demonstrates potential placements of stents to successfully reduce the risk of stroke in patients with aneurysms and intracranial stenosis.

    The growth of global intracranial stents market is expected to be driven by factors such as increasing prevalence of cerebral disorders such as intracranial stenosis and brain aneurysms. Moreover, the government initiatives taken in order to decrease the global burden of brain diseases, technological advancements, extensive research & development and others are also several other factors promoting the growth of global intracranial stents market. However, the inability of these packs to offer optimum pain coverage is expected to hinder the growth of this market. On the other hand, lack of expert professionals to perform stent implantation as well as the high cost of procedures are expected to hinder the growth of this market at certain extent.



    The intracranial stents market report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global intracranial stents market based on type, application, and end user. It also provides market size and forecast till 2025 for overall intracranial stents market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.



    Inquire for Further Detailed Information @ https://www.theinsightpartners.com/discount/TIPHE100001398/?nb





    North America holds a dominant position in the global intracranial stents market which is attributed to high adoption of cranio-maxillofacial by the geriatric population in the region. Moreover, increasing number of innovative product launches through technological advancements contributed from North America is also acting as a driver for the region to dominate the global intracranial stents market. Asia Pacific on the other hand is expected to witness significant traction over the forecast years owing to increasing number of patients suffering from cranial disorders.

    The intracranial stents market report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.

    The intracranial stents market report also includes the profiles of leading intracranial stents manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key developments in past five years. Some of the key players operating the global intracranial stents market include Medtronic, Abbott, Stryker, Balt Extrusion, MicroPort Scientific Corporation, ADMEDES GmbH, Cardiatis, DePuy Synthes, Acandis GmbH, and Penumbra, Inc.


    Rajat Sahni
    +1-646-491-9876
    sales@reportsweb.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, December 14, 2018 ) Research provides an in-depth analysis of the global Menstrual Cups Market with the current trends and future estimations to elucidate the imminent investment pockets.

    "Global Menstrual Cups Market Analysis to 2025" is a specialized and in-depth study of the Menstrual Cups industry with a focus on the global market trend. The report aims to provide an overview of global Menstrual Cups market with detailed market segmentation by component, type, application and geography. The global Menstrual Cups market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.



    Get PDF sample Copy @ https://www.theinsightpartners.com/sample/TIPHE100001400/?nb





    The Report Provides A Detailed Overview Of The Industry Including Both Qualitative And Quantitative Data. It Provides Summary And Forecast Of The World Leading Menstrual Cups Market Supported Product And Application. It Also Provides Market Size And Forecast Till 2025 For Overall Menstrual Cups Market With Regard To 5 Major Regions, Namely; North America, Europe, Asia-Pacific (Apac), Middle East And Africa (Mea) And South America (Sam), Which Is Later Sub-Segmented By Various Countries And Segments. The Report Evaluates Market Dynamics Effecting The Market During The Forecast Period I.E., Drivers, Restraints, Opportunities, And Future Trend And Provides Exhaustive Pest Analysis For All 5 Regions.

    An Exclusive Menstrual Cups Market Analysis Report Created Through Broad Primary Research (Inputs From Industry Specialists, Companies, And Stakeholders) And Secondary Research, The Report Aims To Present The Analysis Of Global Menstrual Cups Market By Type, By Application, By Region - North America, Europe, South America, Asia-Pacific, Middle East And Africa. The Report Intends To Provide Cutting-Edge Market Intelligence And Help Decision Makers Take Sound Investment Evaluation. Besides, The Report Conjointly Identifies And Analyses The Rising Trends Alongside Major Drivers, Challenges And Opportunities Within The International Menstrual Cups Market. Additionally, the Report Also Highlights Market.



    Also, Key Menstrual Cups Market Players Influencing the Market Are Profiled within the Study Along With Their swot Analysis and Market Ways. The Report Also Focuses On Leading Industry Players With Data Like Company Profiles, Products And Services Offered, Financial Information Of Last Three Years, and Key Development In Past 5 Years.



    Inquire for Further Detailed Information @ https://www.theinsightpartners.com/discount/TIPHE100001400/?nb



    Reason to Buy

    · Save And Reduce Time Carrying Out Entry-Level Analysis By Identifying The Growth, Size, Leading Players And Segments Within The Global Menstrual Cups Market

    · Highlights Key Business Priorities in Order to Help Companies to Realign Their Business Strategies.

    · The Key Findings And Recommendations Highlight Crucial Progressive Business Trends Within The Menstrual Cups Market, Thereby Allowing Players To Develop Effective Long Term Strategies.

    · Develop/Modify Business Growth Plans By Using Substantial Growth Providing Developed And Emerging Markets.

    · Scrutinize In-Depth Global Market Trends And Outlook Coupled With The Factors Driving The Market, Similarly As Those Hindering It.

    · Enhance The Decision-Making Process By Understanding The Strategies That Underpin Commercial Interest With Respect To Product, Segmentation And Industry Verticals.



    About Us

    The Insight Partners Is A One Stop Industry Research Provider Of Actionable Intelligence. We Help Our Clients In Getting Solutions To Their Research Requirements Through Our Syndicated And Consulting Research Services.

    We Are Committed To Providing Highest Quality Research And Consulting Services To Our Customers. We Help Our Clients Understand Key Market Trends, Identify Opportunities, And Make Informed Decisions By Providing Market Research Solutions At An Affordable Cost.


    Sameer Joshi
    +1-646-491-9876
    sam@theinsightpartners.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, December 14, 2018 ) The Insight Partners has declared the addition of the “Global Biopsy Devices Market professional Survey Report 2025” The report focuses on world major leading players with info like company profiles, product picture and specification.

    "Global Biopsy Devices Market Analysis to 2025" is a specialized and in-depth study of the Biopsy Devices industry with a focus on the global market trend. The report aims to provide an overview of global Biopsy Devices market with detailed market segmentation by component, type, application and geography. The global Biopsy Devices market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.



    The Report Provides A Detailed Overview Of The Industry Including Both Qualitative And Quantitative Data. It Provides Summary And Forecast Of The World Leading Biopsy Devices Market Supported Product And Application. It Also Provides Market Size And Forecast Till 2025 For Overall Biopsy Devices Market With Regard To 5 Major Regions, Namely; North America, Europe, Asia-Pacific (Apac), Middle East And Africa (Mea) And South America (Sam), Which Is Later Sub-Segmented By Various Countries And Segments. The Report Evaluates Market Dynamics Effecting The Market During The Forecast Period I.E., Drivers, Restraints, Opportunities, And Future Trend And Provides Exhaustive Pest Analysis For All 5 Regions.



    Get PDF sample Copy @ https://www.theinsightpartners.com/sample/TIPHE100001402/?nb

    An Exclusive Biopsy Devices Market Analysis Report Created Through Broad Primary Research (Inputs From Industry Specialists, Companies, And Stakeholders) And Secondary Research, The Report Aims To Present The Analysis Of Global Biopsy Devices Market By Type, By Application, By Region - North America, Europe, South America, Asia-Pacific, Middle East And Africa. The Report Intends To Provide Cutting-Edge Market Intelligence And Help Decision Makers Take Sound Investment Evaluation. Besides, The Report Conjointly Identifies And Analyses The Rising Trends Alongside Major Drivers, Challenges And Opportunities Within The International Biopsy Devices Market. Additionally, the Report Also Highlights Market.



    Also, Key Biopsy Devices Market Players Influencing the Market Are Profiled within the Study Along With Their swot Analysis and Market Ways. The Report Also Focuses On Leading Industry Players With Data Like Company Profiles, Products And Services Offered, Financial Information Of Last Three Years, and Key Development In Past 5 Years.



    Inquire for Further Detailed Information @ https://www.theinsightpartners.com/discount/TIPHE100001402/?nb





    Reason to Buy

    · Save And Reduce Time Carrying Out Entry-Level Analysis By Identifying The Growth, Size, Leading Players And Segments Within The Global Biopsy Devices Market

    · Highlights Key Business Priorities in Order to Help Companies to Realign Their Business Strategies.

    · The Key Findings And Recommendations Highlight Crucial Progressive Business Trends Within The Biopsy Devices Market, Thereby Allowing Players To Develop Effective Long Term Strategies.

    · Develop/Modify Business Growth Plans By Using Substantial Growth Providing Developed And Emerging Markets.

    · Scrutinize In-Depth Global Market Trends And Outlook Coupled With The Factors Driving The Market, Similarly As Those Hindering It.

    · Enhance The Decision-Making Process By Understanding The Strategies That Underpin Commercial Interest With Respect To Product, Segmentation And Industry Verticals.



    About Us

    The Insight Partners Is A One Stop Industry Research Provider Of Actionable Intelligence. We Help Our Clients In Getting Solutions To Their Research Requirements Through Our Syndicated And Consulting Research Services.

    We Are Committed To Providing Highest Quality Research And Consulting Services To Our Customers. We Help Our Clients Understand Key Market Trends, Identify Opportunities, And Make Informed Decisions By Providing Market Research Solutions At An Affordable Cost.


    Sameer Joshi
    +1-646-491-9876
    sam@theinsightpartners.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 14, 2018 ) Anti-Viral Drugs Market Share, Trends, Business Strategy and Forecast to 2023
    Anti-viral drugs are medicines which are used specially for treating viral infections. Most anti-viral drugs are used for particular viral infections, similar to antibiotics, while a broad-spectrum anti-viral drug is effective against a varied range of viruses. Antiviral drugs do not kill their target pathogen, instead they inhibit the development of those viruses. The global anti-viral drugs market is projected to register a moderate growth rate in the pharmaceutical market and which is anticipated to increase due to rise in awareness level, increase in the diseased population and introduction of new drugs with improved efficacy.

    Anti-Viral Drugs Market report provides a thorough synopsis on the study for market and how it is changing the Anti-Viral Drugs Market industry. Report deliver comprehensive analysis of the market structure along with forecast of the various segments and sub-segments of the m market. The Anti-Viral Drugs market report provides an in-depth overview of Product Specification, technology, product type and production analysis considering major factors such as Revenue, Cost, Gross and Gross Margin.
    Get Sample Copy of this Report at https://www.researchreportsinc.com/sample-request?id=231055
    The global Anti-Viral Drugs Market report also contains the drivers and restrains for the market that are derived from SWOT analysis, and also shows what all the recent developments, product launches, joint ventures, merges and accusations by the several key players and brands that are driving the market are by systemic company profiles.
    Antiviral drugs are a class of medication used specifically for treating viral infections rather than bacterial ones
    Over the next five years, Publisher projects that Anti-Viral Drugs will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

    In this report, Publisher covers the present scenario (with the base year being 2017) and the growth prospects of global Anti-Viral Drugs market for 2018-2023.
    This report presents a comprehensive overview, market shares, and growth opportunities of Anti-Viral Drugs market by product type, application, key manufacturers and key regions.

    To calculate the market size, Publisher considers value and volume generated from the sales of the following segments:

    Segmentation by product type:
    Nucleotide Polymerase Inhibitor
    Reverse Transcriptase Inhibitor
    Protease Inhibitor
    Segmentation by application:
    HIV
    Hepatitis
    HSV
    Influenza

    This report also splits the market by region:
    Americas
    United States
    Canada
    Mexico
    Brazil
    APAC
    China
    Japan
    Korea
    Southeast Asia
    India
    Australia
    Europe
    Germany
    France
    UK
    Italy
    Russia
    Spain
    Middle East & Africa
    Egypt
    South Africa
    Israel
    Turkey
    GCC Countries

    Purchase this Premium Report at (Flat 20% off Apply Coupon Code ‘DISC20’):- https://researchreportsinc.com/checkout/?add-to-cart=231055&&attribute_pa_choose-license=single-user&&quantity=1


    The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
    F. Hoffmann-La Roche
    GlaxoSmithKline
    Bristol-Myers-Squibb
    AbbVie
    Johnson & Johnson
    Merck & Co
    Aurobindo Pharma
    Cipla
    Dr Reddy’s

    Table of Contents

    2018-2023 Global Anti-Viral Drugs Consumption Market Report

    1 Scope of the Report
    1.1 Market Introduction
    1.2 Research Objectives
    1.3 Years Considered
    1.4 Market Research Methodology
    1.5 Economic Indicators
    1.6 Currency Considered

    2 Executive Summary
    2.1 World Market Overview
    2.1.1 Global Anti-Viral Drugs Consumption 2013-2023
    2.1.2 Anti-Viral Drugs Consumption CAGR by Region
    2.2 Anti-Viral Drugs Segment by Type
    2.2.1 Nucleotide Polymerase Inhibitor
    2.2.2 Reverse Transcriptase Inhibitor
    2.2.3 Protease Inhibitor
    2.3 Anti-Viral Drugs Consumption by Type
    2.3.1 Global Anti-Viral Drugs Consumption Market Share by Type (2013-2018)
    2.3.2 Global Anti-Viral Drugs Revenue and Market Share by Type (2013-2018)
    2.3.3 Global Anti-Viral Drugs Sale Price by Type (2013-2018)
    2.4 Anti-Viral Drugs Segment by Application
    2.4.1 HIV
    2.4.2 Hepatitis
    2.4.3 HSV
    2.4.4 Influenza
    2.5 Anti-Viral Drugs Consumption by Application
    2.5.1 Global Anti-Viral Drugs Consumption Market Share by Application (2013-2018)
    2.5.2 Global Anti-Viral Drugs Value and Market Share by Application (2013-2018)
    2.5.3 Global Anti-Viral Drugs Sale Price by Application (2013-2018)

    3 Global Anti-Viral Drugs by Players
    3.1 Global Anti-Viral Drugs Sales Market Share by Players
    3.1.1 Global Anti-Viral Drugs Sales by Players (2016-2018)
    3.1.2 Global Anti-Viral Drugs Sales Market Share by Players (2016-2018)
    3.2 Global Anti-Viral Drugs Revenue Market Share by Players
    3.2.1 Global Anti-Viral Drugs Revenue by Players (2016-2018)
    3.2.2 Global Anti-Viral Drugs Revenue Market Share by Players (2016-2018)
    3.3 Global Anti-Viral Drugs Sale Price by Players
    3.4 Global Anti-Viral Drugs Manufacturing Base Distribution, Sales Area, Product Types by Players
    3.4.1 Global Anti-Viral Drugs Manufacturing Base Distribution and Sales Area by Players
    3.4.2 Players Anti-Viral Drugs Products Offered
    3.5 Market Concentration Rate Analysis
    3.5.1 Competition Landscape Analysis
    3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
    3.6 New Products and Potential Entrants
    3.7 Mergers & Acquisitions, Expansion

    4 Anti-Viral Drugs by Regions
    4.1 Anti-Viral Drugs by Regions
    4.1.1 Global Anti-Viral Drugs Consumption by Regions
    4.1.2 Global Anti-Viral Drugs Value by Regions
    4.2 Americas Anti-Viral Drugs Consumption Growth
    4.3 APAC Anti-Viral Drugs Consumption Growth
    4.4 Europe Anti-Viral Drugs Consumption Growth
    4.5 Middle East & Africa Anti-Viral Drugs Consumption Growth

    5 Americas
    5.1 Americas Anti-Viral Drugs Consumption by Countries
    5.1.1 Americas Anti-Viral Drugs Consumption by Countries (2013-2018)
    5.1.2 Americas Anti-Viral Drugs Value by Countries (2013-2018)
    5.2 Americas Anti-Viral Drugs Consumption by Type
    5.3 Americas Anti-Viral Drugs Consumption by Application
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Key Economic Indicators of Few Americas Countries

    6 APAC
    6.1 APAC Anti-Viral Drugs Consumption by Countries
    6.1.1 APAC Anti-Viral Drugs Consumption by Countries (2013-2018)
    6.1.2 APAC Anti-Viral Drugs Value by Countries (2013-2018)
    6.2 APAC Anti-Viral Drugs Consumption by Type
    6.3 APAC Anti-Viral Drugs Consumption by Application
    6.4 China
    6.5 Japan
    6.6 Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 Key Economic Indicators of Few APAC Countries

    7 Europe
    7.1 Europe Anti-Viral Drugs by Countries
    7.1.1 Europe Anti-Viral Drugs Consumption by Countries (2013-2018)
    7.1.2 Europe Anti-Viral Drugs Value by Countries (2013-2018)
    7.2 Europe Anti-Viral Drugs Consumption by Type
    7.3 Europe Anti-Viral Drugs Consumption by Application
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
    7.9 Spain
    7.10 Key Economic Indicators of Few Europe Countries

    8 Middle East & Africa
    8.1 Middle East & Africa Anti-Viral Drugs by Countries
    8.1.1 Middle East & Africa Anti-Viral Drugs Consumption by Countries (2013-2018)
    8.1.2 Middle East & Africa Anti-Viral Drugs Value by Countries (2013-2018)
    8.2 Middle East & Africa Anti-Viral Drugs Consumption by Type
    8.3 Middle East & Africa Anti-Viral Drugs Consumption by Application
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries

    9 Market Drivers, Challenges and Trends
    9.1 Market Drivers and Impact
    9.1.1 Growing Demand from Key Regions
    9.1.2 Growing Demand from Key Applications and Potential Industries
    9.2 Market Challenges and Impact
    9.3 Market Trends

    10 Marketing, Distributors and Customer
    10.1 Sales Channel
    10.1.1 Direct Marketing
    10.1.2 Indirect Marketing
    10.2 Anti-Viral Drugs Distributors
    10.3 Anti-Viral Drugs Customer

    11 Global Anti-Viral Drugs Market Forecast
    11.1 Global Anti-Viral Drugs Consumption Forecast (2018-2023)
    11.2 Global Anti-Viral Drugs Forecast by Regions
    11.2.1 Global Anti-Viral Drugs Forecast by Regions (2018-2023)
    11.2.2 Global Anti-Viral Drugs Value Forecast by Regions (2018-2023)
    11.2.3 Americas Consumption Forecast
    11.2.4 APAC Consumption Forecast
    11.2.5 Europe Consumption Forecast
    11.2.6 Middle East & Africa Consumption Forecast
    11.3 Americas Forecast by Countries
    11.3.1 United States Market Forecast
    11.3.2 Canada Market Forecast
    11.3.3 Mexico Market Forecast
    11.3.4 Brazil Market Forecast
    11.4 APAC Forecast by Countries
    11.4.1 China Market Forecast
    11.4.2 Japan Market Forecast
    11.4.3 Korea Market Forecast
    11.4.4 Southeast Asia Market Forecast
    11.4.5 India Market Forecast
    11.4.6 Australia Market Forecast
    11.5 Europe Forecast by Countries
    11.5.1 Germany Market Forecast
    11.5.2 France Market Forecast
    11.5.3 UK Market Forecast
    11.5.4 Italy Market Forecast
    11.5.5 Russia Market Forecast
    11.5.6 Spain Market Forecast
    11.6 Middle East & Africa Forecast by Countries
    11.6.1 Egypt Market Forecast
    11.6.2 South Africa Market Forecast
    11.6.3 Israel Market Forecast
    11.6.4 Turkey Market Forecast
    11.6.5 GCC Countries Market Forecast
    11.7 Global Anti-Viral Drugs Forecast by Type
    11.8 Global Anti-Viral Drugs Forecast by Application

    12 Key Players Analysis
    12.1 F. Hoffmann-La Roche
    12.1.1 Company Details
    12.1.2 Anti-Viral Drugs Product Offered
    12.1.3 F. Hoffmann-La Roche Anti-Viral Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
    12.1.4 Main Business Overview
    12.1.5 F. Hoffmann-La Roche News
    12.2 GlaxoSmithKline
    12.2.1 Company Details
    12.2.2 Anti-Viral Drugs Product Offered
    12.2.3 GlaxoSmithKline Anti-Viral Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
    12.2.4 Main Business Overview
    12.2.5 GlaxoSmithKline News
    12.3 Bristol-Myers-Squibb
    12.3.1 Company Details
    12.3.2 Anti-Viral Drugs Product Offered
    12.3.3 Bristol-Myers-Squibb Anti-Viral Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
    12.3.4 Main Business Overview
    12.3.5 Bristol-Myers-Squibb News
    12.4 AbbVie
    12.4.1 Company Details
    12.4.2 Anti-Viral Drugs Product Offered
    12.4.3 AbbVie Anti-Viral Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
    12.4.4 Main Business Overview
    12.4.5 AbbVie News
    12.5 Johnson & Johnson
    12.5.1 Company Details
    12.5.2 Anti-Viral Drugs Product Offered
    12.5.3 Johnson & Johnson Anti-Viral Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
    12.5.4 Main Business Overview
    12.5.5 Johnson & Johnson News
    12.6 Merck & Co
    12.6.1 Company Details
    12.6.2 Anti-Viral Drugs Product Offered
    12.6.3 Merck & Co Anti-Viral Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
    12.6.4 Main Business Overview
    12.6.5 Merck & Co News
    12.7 Aurobindo Pharma
    12.7.1 Company Details
    12.7.2 Anti-Viral Drugs Product Offered
    12.7.3 Aurobindo Pharma Anti-Viral Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
    12.7.4 Main Business Overview
    12.7.5 Aurobindo Pharma News
    12.8 Cipla
    12.8.1 Company Details
    12.8.2 Anti-Viral Drugs Product Offered
    12.8.3 Cipla Anti-Viral Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
    12.8.4 Main Business Overview
    12.8.5 Cipla News
    12.9 Dr Reddy’s
    12.9.1 Company Details
    12.9.2 Anti-Viral Drugs Product Offered
    12.9.3 Dr Reddy’s Anti-Viral Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
    12.9.4 Main Business Overview
    12.9.5 Dr Reddy’s News

    13 Research Findings and Conclusion

    Have Any Query? Ask Our Experts @ https://researchreportsinc.com/enquiry?id=231055


    In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

    Research objectives
    To study and analyze the global Anti-Viral Drugs consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
    To understand the structure of Anti-Viral Drugs market by identifying its various subsegments.
    Focuses on the key global Anti-Viral Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
    To analyze the Anti-Viral Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    To project the consumption of Anti-Viral Drugs submarkets, with respect to key regions (along with their respective key countries).
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
    To strategically profile the key players and comprehensively analyze their growth strategies.

    Research Reports Inc. is one of the leading destinations for market research reports across all industries, companies, and technologies. Our repository features an exhaustive list of market research reports from thousands of publishers worldwide.




    Shubham Goel
    8554192424
    sales@researchreportsinc.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 15, 2018 ) According to the new market research report "Home Healthcare Market by Product (BP & Heart Rate Monitor, Ovulation Kit, HIV Test, ECG, Nebulizer, Hearing Aids, Pedometer, Cane, Crutches, Wheelchair), Software, Services (Rehabilitation, Pregnancy, Palliative), & Telehealth - Global Forecast to 2022", published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints/challenges, and opportunities.

    The global home healthcare market is expected to reach USD 364.69 Billion by 2022 from USD 220.67 Billion in 2016, at a CAGR of 8.8%. The base year considered for the study is 2016 and the forecast period is from 2017 to 2022.

    Browse and in-depth TOC on "Home Healthcare Market "
    73 - Tables
    36 - Figures
    156 - Pages
    View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/home-healthcare-equipment-market-696.html

    The global home healthcare market is expected to reach USD 364.69 Billion by 2022 from USD 239.30 Billion in 2017, at a CAGR of 8.8%. The growth of this market is mainly driven by the growing geriatric population; increasing incidence of chronic diseases; and rising demand for affordable healthcare delivery systems due to increasing healthcare cost, technological advancements, and government initiatives to promote home healthcare.
    This report segments the home healthcare market into product, service, software, telehealth solutions, and region. Based on product, the market is segmented into testing, screening, & monitoring products; therapeutic products; and mobility care equipment. The mobility care segment is slated to register the highest CAGR during the forecast period due to the growing geriatric population, ease of use, rising demand for personal independence, and social connectedness. These devices also offer personal security and safety.

    Avail Discount on Report - https://www.marketsandmarkets.com/discountreports.asp?id=696

    In 2017, North America is expected to dominate the market followed by Europe. The large share of this geographical segment is attributed to factors such as converging trends of aging population, technological advancement, and rising incidence of chronic diseases.
    Asia is expected to grow at the highest CAGR during the forecast period. Factors such as rising geriatric population, increasing adoption of innovative techniques, increasing disposable income, expansion of home healthcare companies in this region, rising awareness of home healthcare, and increasing need for affordable healthcare delivery systems are expected to drive the growth of this market in Asia.

    Changing reimbursement policies, limited insurance coverage, and patient safety concerns may limit market growth to a certain extent in the coming years. The home healthcare market is highly competitive with the presence of several small and big players.

    Key Players
    Prominent players in the home healthcare market include Philips Healthcare (Netherlands), Kindred Healthcare (US), Linde Group (Germany), Almost Family Inc. (US), Abbott Laboratories (US), LHC Group (US), A&D (Japan), Amedisys (US), Fresenius (Germany), Omron (Japan), McKesson (US), BAYADA Home Health Care (US), Kinnser Software, Inc. (US), and Roche (Switzerland).

    Click for Adjacent Markets Report Available - Request for bundle reports: https://www.marketsandmarkets.com/RequestBundleReport.asp?id=696



    Mr. Shelly Singh
    1-888-600-6441
    sales@marketsandmarkets.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 15, 2018 ) According to the new market research report “Autoinjectors Market by Therapy (Rheumatoid Arthritis, Multiple Sclerosis, Anaphylaxis, Cardiovascular diseases, Psoriasis, Migraine), Type (Disposable, and Reusable), End Users (Homecare, and Hospitals) - Global Forecast to 2023", published by MarketsandMarkets™, The global autoinjectors market is projected to reach USD 85.31 billion by 2023 from an estimated USD 28.91 billion in 2018, at a CAGR of 24.2% during the forecast period (2018-2023). The key factors driving the growth of this market include the growing prevalence of targeted therapies such as rheumatoid arthritis and multiple sclerosis, rising incidence of anaphylaxis, and increasing number of regulatory approvals.

    Early buyers will receive 10% customization on reports @ https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=173991724

    The market is mainly driven by factors such as growing prevalence of targeted therapies, rising incidence of anaphylaxis, increasing number of regulatory approvals, and availability of generic versions of autoinjectors.

    Autoinjectors are easy-to-handle and cost-effective medical devices that can be used by patients, caregivers, and even untrained personnel to deliver a dose of a particular drug. Autoinjectors are used by patients to manage autoimmune diseases and chronic diseases. They are used for a wide range of indications such as rheumatoid arthritis, multiple sclerosis, diabetes, and anaphylaxis.

    On the basis of type, the autoinjectors market is segmented into disposable and reusable autoinjectors. The disposable autoinjectors segment is expected to account for the largest market share in 2017. This can primarily be attributed to their ease of use and the presence of a built-in glass syringe which makes it more convenient for patients with reduced dexterity or visual impairments.

    Browse and in-depth TOC on “Autoinjectors Market”
    66 - Tables

    36 - Figures

    133 - Pages

    Request Bundle Reports @ https://www.marketsandmarkets.com/RequestBundleReport.asp?id=173991724

    Preference for alternative drug delivery modes such as oral diabetic agents, oral insulin, and epinephrine nasal sprays is a major factor restraining the growth of the market. Traditional injectables are invasive and painful modes of drug delivery owing to which patients and care providers are increasingly focusing on alternative routes of drug delivery, such as oral, topical, and nasal routes. Among the various routes of drug delivery, the oral route is the most preferred as it is easy to use, convenient, cost-effective, safe, and acceptable. Moreover, the introduction of needle-free drug delivery devices such as jet injectors also restricts the growth of the autoinjectors market.

    Key players in market include Abbvie (US), Amgen (US), Teva (Israel), Biogen (US), Eli Lilly (US), and Mylan (US). These players adopted growth strategies such as product launches, product approvals, agreements and expansions to maintain and enhance their position in the market. Other prominent players in the market include Ypsomed (Switzerland), Merck (Germany), AstraZeneca (UK), J&J (US), Bayer (Germany), Becton, Dickinson and Company (US), Owen Mumford (UK), Novartis (Switzerland), and Haselmeier (Switzerland).

    About MarketsandMarkets™

    MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

    Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

    MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

    Contact:

    Mr. Shelly Singh
    MarketsandMarkets™ INC.
    630 Dundee Road
    Suite 430
    Northbrook, IL 60062
    USA: 1-888-600-6441
    Email: sales@marketsandmarkets.com
    Visit Our Website: https://www.marketsandmarkets.com


    Mr. Shelly Singh
    1-888-600-6441
    sales@marketsandmarkets.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 15, 2018 ) According to the new market research report “Genotyping Market by Technology (PCR, Sequencing, Microarray, Electrophoresis, MALDI-TOF), Application (Pharmacogenomics, Diagnostic Research, Animal Genetics, Agricultural Biotechnology), and Product - Global Forecast to 2023", published by MarketsandMarkets™, The genotyping assay market is expected to reach USD 31.9 billion by 2023 from an estimated USD 11.8 billion in 2018, at a CAGR of 22.0%.

    Get 10% Customization on this Report @ https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=249958595

    The growth of this market is mainly driven by technological advancements, the decreasing prices of DNA sequencing, and the increasing incidence of genetic diseases.

    The genotyping market in the APAC is expected to grow at the highest CAGR during the forecast period. This is due to the increasing incidence of chronic diseases, and growing awareness on the use of genotyping tests to control the inheritance of genetic diseases and the spread of infectious and microbial diseases in APAC countries. Global pharmaceutical and biopharmaceutical companies are also increasingly outsourcing clinical research and trials to companies in this region, which has increased the demand for genotyping products for drug profile assessment, drug efficacy and safety assessment, dosing determination, and drug response evaluation.

    The reagents & kits segment is expected to grow at the highest CAGR during the forecast period
    Based on product, the reagents and kits are expected to grow at the highest rate during the forecast period. This segment is expected to witness the highest CAGR due to the easy accessibility of a wide range of reagents and the increasing need for genotyping in various applications.

    Browse and in-depth TOC on “Genotyping Market”
    219 - Tables

    53 - Figures

    280 - Pages

    Request Bundle Reports @ https://www.marketsandmarkets.com/RequestBundleReport.asp?id=249958595

    The prominent players in the global genotyping market are Thermo Fisher Scientific (US), Illumina (US), QIAGEN (Netherlands), Agilent Technologies (US), Danaher Corporation (US), Roche Diagnostics (Switzerland), GE Healthcare (US), Fluidigm Corporation (US), PerkinElmer (US), Eurofins Scientific (Luxembourg), Bio-Rad Laboratories (US), Pacific Biosciences of California (US), GENEWIZ (US), and Integrated DNA Technologies (US).

    About MarketsandMarkets™

    MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

    Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

    MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

    Contact:

    Mr. Shelly Singh
    MarketsandMarkets™ INC.
    630 Dundee Road
    Suite 430
    Northbrook, IL 60062
    USA: 1-888-600-6441
    Email: sales@marketsandmarkets.com
    Visit Our Website: https://www.marketsandmarkets.com


    Mr. Shelly Singh
    1-888-600-6441
    sales@marketsandmarkets.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, December 15, 2018 ) Global Portable Computerized Tomography Scanners Market report is replete with detailed analysis from a thorough research, especially on questions that border on market size, development environment, futuristic developments, operation situation, pathways and trend of Portable Computerized Tomography Scanners. All these are offshoots of understanding the current situation that the industry is in, especially in 2018. The will chart the course for a more comprehensive organization and discernment of the competition situation in the Portable Computerized Tomography Scanners market. As this will help manufacturers and investors alike, to have a better understanding of the direction in which the Portable Computerized Tomography Scanners Market is headed.
    Access complete report at: https://www.themarketreports.com/report/global-portable-computerized-tomography-scanners-market-research-report-2018

    With this Portable Computerized Tomography Scanners Market report, one is sure to keep up with information on the dogged competition for market share and control, between elite manufacturers. It also features, price, production, and revenue. It is where you will understand the politics and tussle of gaining control of a huge chunk of the market share. As long as you are in search of key Industry data and information that can readily be accessed, you can rest assured that this report got them covered. Key companies profiled in this report are Medtronic, Philips Healthcare, NeuroLogica, GE Healthcare, LifeHealthcare, Providian Medical, Gamma Star and others.
    Purchase a copy of this report at: https://www.themarketreports.com/report/buy-now/1346682

    When taking a good look at this report, based on the product, it is evident that the report shows the rate of production, price, revenue, and market share as well as of the growth of each product type. And emphasis is laid on the end users, as well as on the applications of the product. It is one report that hasn't shied away from taking a critical look at the current status and future outlook for the consumption/sales of these products, by the end users and applications. Not forgetting the market share control and growth rate of Portable Computerized Tomography Scanners Industry, per application.
    All the queries about this report can be asked at: https://www.themarketreports.com/report/ask-your-query/1346682

    List of Chapters:
    1 Portable Computerized Tomography Scanners Market Overview
    2 Global Portable Computerized Tomography Scanners Market Competitions by Manufacturers
    3 Global Portable Computerized Tomography Scanners Capacity, Production, Revenue (Value) by Region (2013-2018)
    4 Global Portable Computerized Tomography Scanners Supply (Production), Consumption, Export, Import by Region (2013-2018)
    5 Global Portable Computerized Tomography Scanners Production, Revenue (Value), Price Trend by Type
    6 Global Portable Computerized Tomography Scanners Market Analysis by Application
    7 Global Portable Computerized Tomography Scanners Manufacturers Profiles/Analysis
    8 Portable Computerized Tomography Scanners Manufacturing Cost Analysis
    9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    10 Marketing Strategy Analysis, Distributors/Traders
    11 Market Effect Factors Analysis
    12 Global Portable Computerized Tomography Scanners Market Forecast (2018-2025)
    13 Research Findings and Conclusion
    14 Appendix
    The Market Reports
    We aim to provide the best industry and market research report to a seeker. Today, ‘The Market Reports’ is a one stop destination for all the report buyers. We have a collection of over 700,000+ research, company, market, SWOT, trends and analysis reports of various countries, categories and domain to meet an organization need.
    Website: https://www.themarketreports.com/
    Write us at sales@themarketreports.com
    Call at +1-631-407-1315 / +91-750-729-1479


    Shirish Gupta
    +1-631-407-1315
    web@themarketreports.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, December 15, 2018 ) Global Veterinary Vaccine Market report is replete with detailed analysis from a thorough research, especially on questions that border on market size, development environment, futuristic developments, operation situation, pathways and trend of Veterinary Vaccine. All these are offshoots of understanding the current situation that the industry is in, especially in 2018. The will chart the course for a more comprehensive organization and discernment of the competition situation in the Veterinary Vaccine market. As this will help manufacturers and investors alike, to have a better understanding of the direction in which the Veterinary Vaccine Market is headed.
    Access complete report at: https://www.themarketreports.com/report/global-veterinary-vaccine-market-research-report-2018

    With this Veterinary Vaccine Market report, one is sure to keep up with information on the dogged competition for market share and control, between elite manufacturers. It also features, price, production, and revenue. It is where you will understand the politics and tussle of gaining control of a huge chunk of the market share. As long as you are in search of key Industry data and information that can readily be accessed, you can rest assured that this report got them covered. Key companies profiled in this report are Merck, Merial, Boehringer Ingelheim, Zoetis, Virbac, Ceva, Elanco/Eli Lilly, Sindh Poultry Vaccine Centre and others.
    Purchase a copy of this report at: https://www.themarketreports.com/report/buy-now/1198898

    When taking a good look at this report, based on the product, it is evident that the report shows the rate of production, price, revenue, and market share as well as of the growth of each product type. And emphasis is laid on the end users, as well as on the applications of the product. It is one report that hasn't shied away from taking a critical look at the current status and future outlook for the consumption/sales of these products, by the end users and applications. Not forgetting the market share control and growth rate of Veterinary Vaccine Industry, per application.
    All the queries about this report can be asked at: https://www.themarketreports.com/report/ask-your-query/1198898

    List of Chapters:
    1 Veterinary Vaccine Market Overview
    2 Global Veterinary Vaccine Market Competitions by Manufacturers
    3 Global Veterinary Vaccine Capacity, Production, Revenue (Value) by Region (2013-2018)
    4 Global Veterinary Vaccine Supply (Production), Consumption, Export, Import by Region (2013-2018)
    5 Global Veterinary Vaccine Production, Revenue (Value), Price Trend by Type
    6 Global Veterinary Vaccine Market Analysis by Application
    7 Global Veterinary Vaccine Manufacturers Profiles/Analysis
    8 Veterinary Vaccine Manufacturing Cost Analysis
    9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    10 Marketing Strategy Analysis, Distributors/Traders
    11 Market Effect Factors Analysis
    12 Global Veterinary Vaccine Market Forecast (2018-2025)
    13 Research Findings and Conclusion
    14 Appendix
    The Market Reports
    We aim to provide the best industry and market research report to a seeker. Today, ‘The Market Reports’ is a one stop destination for all the report buyers. We have a collection of over 700,000+ research, company, market, SWOT, trends and analysis reports of various countries, categories and domain to meet an organization need.
    Website: https://www.themarketreports.com/
    Write us at sales@themarketreports.com
    Call at +1-631-407-1315 / +91-750-729-1479


    Shirish Gupta
    +1-631-407-1315
    web@themarketreports.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 15, 2018 ) According to the latest market report published by Fact MR, titled ‘Global Wound Irrigation Solution Market: Forecast, Trend Analysis & Competition Tracking - Global Review: 2018- 2028’, the global wound irrigation solution market is expected to expand at a significant CAGR during the forecast period 2018–2028.

    The wound irrigation solution market is segmented based on product type, end user and region. On the basis of product type, the wound irrigation solution market has been segmented into two segments such as wetting agents and antiseptics. The antiseptics segment of wound irrigation solution market is expected to be the fast-growing segment over the forecast period, registering a significant CAGR in terms of growth, whereas wetting agents segment is expected to maintain dominance in terms of revenue in the wound irrigation solution market. The increasing demand for advanced wound care solution owing to the growing number of chronic wounds worldwide is expected to boost the growth of the wound irrigation solution market over the forecast period.

    The wetting agents segment dominated the wound irrigation solution market with significant a market value in 2017. Also, the segment is expected to maintain its dominance in the wound irrigation solution market with a significant value by 2028 end.

    Click here to subscribe Sample @ https://www.factmr.com/connectus/sample?flag=S&rep_id=1166 

    On the basis of end users, the wound irrigation solution market has been segmented into hospitals, ambulatory surgical centers, clinics, long term care centers and home care settings.

    On the basis of region, the wound irrigation solution market has been segmented into North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding Japan (APEJ), Japan and the Middle East and Africa (MEA).

    Increasing prevalence of acute and chronic wounds coupled with increasing adoption of wound irrigation solution in wound care is expected to boost the growth of the wound irrigation solution market over the forecast period. With increasing prevalence of chronic and acute wounds, several healthcare facilities are focusing on implementing educational programs to raise awareness regarding benefits of wound irrigation solution, including the mandatory use of wound irrigation solution before the dressing of a wound. Increasing preference of wound irrigation solution on the account of their high specificity and efficacy in cleaning and healing of wounds with strong presence of distribution channel is further expected to drive the growth of the wound irrigation solution market over the forecast period. Rising aging population with diabetes causing pressure ulcer, increasing adoption of advance wound care products and growing acceptance of standardized protocols to manage complex wounds are also expected to drive the growth of the wound irrigation solution market over the forecast period. Growing focus of leading wound irrigation solution manufacturers on emerging economies such as India and China is estimated to have a positive impact on the wound irrigation solution market in Asia-Pacific. However, innovating the wound irrigation solutions by enhancing their ability to retain moisture balance and ingraining extended oxygen permeability and antimicrobial activity along with availability of expanded product line for wound care are factors also expected to drive the growth of the wound irrigation solution market in North America and Europe over the forecast period.

    Speak with an Analyst to learn more (methodology) @ https://www.factmr.com/connectus/sample?flag=RM&rep_id=1166 

    However, limited awareness about available treatment options among general population, lack of reimbursement and higher demand for low frequency dressing change in acute care settings are factors that may hamper the demand for wound irrigation solution and restrain the growth of wound irrigation solution market over the forecast period.

    This report assesses trends driving the growth of segmental wound irrigation solution markets and offers analysis and insights into the regional wound irrigation solution market. North America is estimated to dominate the wound irrigation solution market with a maximum value share by the end of 2018.

    Examples of some the key wound irrigation solution market companies covered in this report include Schulke & Mayr, Reckitt Benckiser Group plc., B. Braun Melsungen AG, ConvaTec Group plc., Anacapa Technologies, Becton, Dickinson and Company, Coloplast A/S, 3M Company, SteadMed Medical and Integra Life Sciences Corporation. These leading players focus on to consolidate their position in the global wound irrigation solution market by actively participating in activities such as partnerships, mergers, acquisitions and collaborations.

    Report Analysis@ https://www.factmr.com/report/1166/wound-irrigation-solution-market 

    The global wound irrigation solution market is segmented as follows:

    By Product Type

    Wetting agents
    Antiseptics
    By End User

    Hospitals
    Ambulatory Surgical Centers
    Clinics
    Long Term Care Centers
    Home Care Settings
    By Region

    North America (U.S., Canada)
    Latin America (Mexico, Brazil, Argentina, Chile, Peru)
    Western Europe (Germany, Italy, France, U.K, Spain, BENELUX, Nordic, Eastern Europe)
    CIS and Russia
    Asia-Pacific (China, India, ASEAN, South Korea)
    Japan
    Middle East and Africa (GCC Countries, South Africa, Turkey, Iran, Israel)
    Get Access to Report @ https://www.factmr.com/checkout/1166/S 


    James Hilton
    +353-1-6111-593
    info@factmr.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 15, 2018 ) The orthopedic implants market continues to be a promising avenue in the global medical technology space. Emergence of advanced technologies coupled with rise in orthopedic disorders are major growth determinants for the orthopedic implants market. A recent report by Fact.MR envisions the orthopedic implants market to record an august 6.5% CAGR over the forecast period 2018 to 2027. Although surgeries of orthopedic implants incorporating robotics offer reproducible precision and are less invasive, expensiveness of the technology coupled with the requirement for robust, evidence-based studies continues to impede its adoption in orthopedic surgeries.

    The report opines that knee reconstruction will continue to hold major revenue shares of the orthopedic implants market, trailed by hip reconstruction. Governments across the globe are taking efforts to reduce prices of orthopedic implants used in knee reconstruction surgeries. For example, the National Pharmaceutical Pricing Authority (NPPA) has announced price caps on the orthopedic implants employed in knee reconstruction surgeries, bringing the basic models’ price down by 65%.

    Click here to subscribe Sample @ https://www.factmr.com/connectus/sample?flag=S&rep_id=990 

    Additionally, the NPPA has also passed off most of the margins in trade, thereby alleviating concerns regarding impact of the orthopedic implants’ reduced prices on research & innovation. Such efforts from the government will further underpin growth of the orthopedic implants market in the near future. Orthopedic implant sales for knee reconstruction are envisaged to increase at 6.3% CAGR through 2027, according to Fact.MR study. In case of hip reconstruction surgeries, dislocation of orthopedic implants has prevailed as a prominent concern among patients and healthcare professionals alike.

    A recent study carried out by a well-known research director, Geoffrey Westrich, unveiled that patients receiving newer implants, referred to “dual mobility,” has zero dislocation tendency in hip reconstruction and replacement. Researchers have found out dual-mobility orthopedic implants to have no dislocations post three-year follow-up of patients.

    Speak with an Analyst to learn more (methodology) @ https://www.factmr.com/connectus/sample?flag=RM&rep_id=990 

    Results of the study are considered encouraging to meet active, high demand for orthopedic implants among patients, and are likely to lessen concerns apropos of dislocation. Such novel revelations and discoveries will continue to propel demand for orthopedic implants associated with hip reconstruction. Revenues from sales of orthopedic implants for hip reconstructed exceeded US$ 16,800 Mn in 2017.

    North America’s preeminent in the orthopedic implants market will continue to prevail, states Fact.MR study. According to American Joint Replacement Registry (AJRR), over 7 million America have been associated with knee and hip reconstruction surgeries collectively. Over half revenue share of the market will be accounted by orthopedic implants sales in North America by 2027-end.

    The U.S. Food and Drug Administration (FDA) has approved a slew of robotic surgery systems for orthopedic implants, with the da Vinci Surgical System being the first one. More companies have been investing in the technology for providing a better navigation during the procedure, and obtain 3D scans to aid designing of customized joints.

    Report Analysis@ https://www.factmr.com/report/990/orthopedic-implants-market 

    Acquisitions and mergers continue to be key strategic expansion methods adopted by companies operating in the orthopedic implants market. Acquisition of Mako Surgical Corp. by Stryker – for total hip and knee construction robotic products for orthopedic implants, and Blue Belt Holdings by Smith & Nephew for robot-assisted orthopedic implant surgery product for partial knee replacements are prime instances of such strategic expansions.

    Continues advancements in orthopedics have resulted in the development of new, novel implants, with several of them being employed in clinical practices with none or little evidence on their effectiveness and safety. Appropriate staging of new orthopedic implants implementation is therefore gaining emphasis in the market, to eliminate relevant adverse effects on patients. Methodologies for evaluation of new orthopedic implants are now being used as a base for contemplating their success and resolving observed drawbacks.

    Get Access to Report @ https://www.factmr.com/checkout/990/S 


    James Hilton
    +353-1-6111-593
    info@factmr.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 17, 2018 ) The key factors driving the growth of this market include increasing adoption of big data, wearable devices, and IoT in healthcare; advantages of cloud usage (such as improved storage, flexibility, and scalability of data); implementation of healthcare reforms such as the Patient Protection and Affordable Care Act; and the dynamic nature of health benefit plan design.

    By application, the clinical information systems segment held the largest share of the market in 2018

    By application, the healthcare cloud computing market is segmented into clinical information systems and the nonclinical information systems. In 2018, the clinical information systems segment is expected to account for the largest share of the global market. The large share of this segment can be primarily attributed to rising prevalence of chronic disease and rising geriatric population leading to increasing volume of patient data.

    Download the PDF Brochure@
    https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=347

    By deployment model, the private cloud segment held the largest share of the market in 2018

    By application, the healthcare cloud computing market is segmented into private cloud, hybrid cloud, and public cloud models. In 2018, the private cloud segment is expected to account for the largest share of the global market. The large share of this segment can be primarily attributed to its higher adoption owing to its better security.

    By component, the services segment held the largest share of the market in 2018

    By component, the healthcare cloud computing market is segmented into software and services. In 2018, the services segment is expected to account for the largest share of the global market. The large share of this segment can be attributed to the recurring nature of services such as training and education, installation, software upgrades, consulting, and maintenance.

    North America to dominate the market in 2018

    In 2018, North America held the largest share of the healthcare cloud computing market, followed by Europe. Factors such as the increasing adoption of EHRs among medical professionals and active participation by private sector players in the development of the healthcare industry in that region are contributing to the dominant share of this region.

    Get the Sample Pages@
    https://www.marketsandmarkets.com/requestsampleNew.asp?id=347

    Some of the players in the global healthcare cloud computing market are CareCloud Corporation (US), ClearData Networks Inc. (US), Athenahealth (US), Cerner Corporation (US), Epic Systems Corporation (US), NextGen Healthcare (US), Carestream Corporation (Canada), Dell Inc. (US), DICOM Grid Inc. (US), INFINITT Healthcare (South Korea), Sectra AB (Sweden), Merge Healthcare Inc. (US), Siemens Healthineers (Germany), iTelagen Inc. (US), NTT DATA Corporation (Japan), Nuance Communications (US), and Ambra Health (US).

    About MarketsandMarkets™

    MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

    Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

    MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

    Contact:
    Mr. Shelly Singh
    MarketsandMarkets™ INC.
    630 Dundee Road
    Suite 430
    Northbrook, IL 60062
    USA : 1-888-600-6441
    sales@marketsandmarkets.com


    Mr. Shelly Singh
    1-888-600-6441
    sales@marketsandmarkets.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 17, 2018 ) Factors such as the implementation of initiatives to shift the burden of risk from healthcare payers to providers, government initiatives and regulations promoting patient-centric care, initiatives to promote healthcare IT, rising geriatric population, and need to reduce healthcare costs are driving the growth of the care management solutions market.

    By application, disease management solutions are expected to account for the largest share of the market in 2018

    On the basis of applications, the care management solutions market is broadly segmented into disease management, case management, utilization management, other applications. In 2018, the disease management segment is expected to account for the largest share of this market. The high growth in this segment can be attributed to the ability of these solutions to reduce the cost of care with the help of protocol management and prevent episodes of ill health through comprehensive health management.

    Download the PDF Brochure@
    https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=19482811

    By end user, the payers segment is expected to command the largest share of the market in 2018

    On the basis of end user, the market has been segmented into payers, providers, and other end users. The payers segment is expected to command the largest share of the market in 2018. The deployment of care management solutions is increasing among payers as it helps them in the effective management of patient health records, claims processing and reimbursement tasks, coordinating care for their members, and ensuring better health outcomes to mitigate their risk burden. The growing stringency of regulations for payers is another important factor driving the adoption of care management solutions in this end-user segment.

    North America to dominate the market in 2018

    North America is expected to account for the largest share of the care management solutions market in 2018, followed by Europe. The large share of North America can be attributed to the increased adoption of care management solutions by healthcare providers and payers to meet the healthcare goals of better quality care and lower healthcare costs. Also, several major global players are based in the US, owing to which the US has become a center for innovation in the care management solutions market.

    EXL Service Holdings, Inc. (US), Casenet, LLC (US), Medecision Inc. (US), ZeOmega Inc. (US), Cognizant Technology Solutions (US), Cerner Corporation (US), Allscripts Healthcare Solutions, Inc. (US), and TCS Healthcare Technologies (US) are the key players in the care management solutions market. Other players involved in this market are Koninklijke Philips N.V. (Netherlands), IBM Corporation (US), Health Catalyst Inc. (US), Harmony Information Systems, Inc. (US), Salesforce.com, Inc. (US), i2i Systems, Inc. (US), Pegasystems Inc. (US), and Epic Corporation Inc. (US).

    Get the Sample Pages@
    https://www.marketsandmarkets.com/requestsampleNew.asp?id=19482811

    About MarketsandMarkets™

    MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

    Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

    MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

    Contact:
    Mr. Shelly Singh
    MarketsandMarkets™ INC.
    630 Dundee Road
    Suite 430
    Northbrook, IL 60062
    USA : 1-888-600-6441
    sales@marketsandmarkets.com


    Mr. Shelly Singh
    1-888-600-6441
    sales@marketsandmarkets.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 15, 2018 ) With the rise in emphasis on prevention and treatment of proliferative vitreoretinopathy (PVR), a serious ailment that leads to blindness despite repeated treatment, the requirement for vitreoretinal centers has gained importance worldwide. Prevention of PVR development at early stage RRD for preserving visual function in patients has become a primary agenda among medical researchers and clinicians. A recent Fact.MR analysis envisages the proliferative vitreoretinopathy market to reflect a modest 4.0% CAGR during the forecast period (2018-2027).?

    However, establishment of vitreoretinal centers for the provision of advanced ophthalmological procedures is considered impractical, on account of increasing social security costs – a key challenge faced by nations across the globe. In contrast, remarkable advances have been made in medical equipment, and ultra-wide-field scanning laser ophthalmoscope (Optos) is one such advancement. This equipment facilitates the provision of wide-field, noninvasive, and nonmydriatic images, and is being increasingly employed for diagnosis and follow-up of PVR treatment evaluation.

    Advantages of deep learning in classifying Optus images in RRD have been observed to be slight, however the method has been deemed clinically imperative to achieve higher accuracy. It has been observed that multiple non-linear processing layers in deep learning approach can be leveraged for effective prevention and treatment of proliferative vitreoretinopathy by further studies.

    Click here to subscribe Sample @ https://www.factmr.com/connectus/sample?flag=S&rep_id=795 

    Proliferative Vitreoretinopathy Market: Hospital Pharmacies Continue to Account for Bulk Market Shares

    Hospital pharmacies are leading consumers in the pharmacy industry. Policymakers are becoming more aware about importance of offering effective pharmacy services coupled with safe and rational use of medications. In case of proliferative vitreoretinopathy, hospital pharmacies are considered to be radical asset of the modern pharmacy sector. They are vital part of hospitals and clinics, ensuring safe, effective, and economic use of drugs. According to the study, hospital pharmacies will continue to account for bulk shares of the market in the period of forecast.

    Injectables will remain preferred over other mode of administrations of proliferative vitreoretinopathy management drugs. Treatment of PVR through intravitreal injectables has been considered beneficial as they delivery drugs directly to retina and vitreous. Simplicity of achieving intravitreal injection by doctors is a key factor driving adoption of this method. Subretinal injection has been gaining ground in the treatment of PVR, as it directly affects the resident cells & tissues in subretinal space. However, requirement for highly proficient and stable operators for subretinal injection continues to prevail as a major concern in the healthcare sector.

    Speak with an Analyst to learn more (methodology) @ https://www.factmr.com/connectus/sample?flag=RM&rep_id=795 

    Proliferative Vitreoretinopathy Market: North America Remains at the Vanguard

    North America will continue to be at the forefront of the proliferative vitreoretinopathy market, with approximately two-fifth market revenue share estimated for the region by 2027-end. Favorable government policies and reimbursements provided by the government, along with the occupancy of robust healthcare facilities are key growth determinants for growth of the proliferative vitreoretinopathy market in North America. Additionally, strong penetration of PVR management drugs such as “lornoxicam” has further supported demand for treatment of PVR in the region.

    Recent studies state that high level of vascular endothelial growth factor (VEGF) have been detected in the fibrovascular tissues of the eyes, which has prompted use of anti-VEGF as the most effective & efficient management method, in patients with proliferative vitreoretinopathy. Emergence and robust adoption of intravitreal pharmacologic agents, particularly drugs that inhibit the actions of VEGF, have directed focus of approach toward the proliferative vitreoretinopathy therapeutics from vision stabilization to vision improvement. Improvement in the patient’s visual acuity while undergoing RRD via utilization of anti-VEGF has been deemed more effective compared to improvements observed in the treatment using corticosteroids.

    Report Analysis@ https://www.factmr.com/report/795/proliferative-vitreoretinopathy-market 


    James Hilton
    +353-1-6111-593
    info@factmr.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 15, 2018 ) Efficacy of neonatal ventilators in reducing infant mortality continues to drive their adoption in healthcare settings, finds a new Fact.MR study. Global sales are likely to surpass 19,000 units in 2018, equating a market value of over US$ 440 Mn. End-users continue to show a marked affinity for hybrid neonatal ventilators that offer the advantages of both invasive and non-invasive variants.

    The neonatal ventilator landscape continues to be massively influenced by advances in automation and integration of technology. To create product differentiation, manufacturers are focusing on equipping their offerings with enhanced safety features, and compatibility with electronic record systems.

    The report finds that infant-to-adult ventilators remain an appealing prospect for end-users, but these devices are beset with challenges. The one-size-fits-all approach of infant-to-adult ventilators manufacturers continues to impede widespread adoption. Infant-to-adult ventilator manufacturers are focusing on enhancing patient safety to leverage the opportunities in this landscape. Features such as prioritized alarm messages, customized data displays, and automated weaning software being incorporated by end-users.

    Click here to subscribe Sample @ https://www.factmr.com/connectus/sample?flag=S&rep_id=758 

    Improving efficiency and reducing the overall cost of care is a key focus area for hospitals, clinics, and ambulatory surgical centers. Sensing the needs of end-users, infant ventilator manufacturers are focusing on developing innovative products that deliver invasive, non-invasive, and oxygen therapy. However, the report finds that ventilator manufacturers need to address the specific challenges associated with neonatal ventilation, such as smaller inspiratory volumes, quick gas flow changes, and protection against high airway pressures.

    The report finds that end-users have a marked preference for standalone neonatal ventilator devices, vis-à-vis portable and transportable devices. Sales of standalone neonatal ventilator devices are likely to reach US$ 229 Mn in 2018, whereas transportable neonatal ventilator devices are likely to account for the lowest market share.

    Speak with an Analyst to learn more (methodology) @ https://www.factmr.com/connectus/sample?flag=RM&rep_id=758 

    Demand for neonatal ventilators will continue to remain robust in hospitals, followed by nursing homes and neonatal clinics. Hospitals account for nearly 45% revenue share of the market, and it is likely that status quo will remain unchanged during the assessment period. However, demand for neonatal ventilators is likely to witness the fastest growth in neonatal clinics. The report finds that in spite of growing at a higher rate, neonatal clinics will not surpass hospitals as the largest end-user globally by 2028.

    The US continues to be the largest market for neonatal ventilators globally. The report finds that in addition to being a lucrative market in terms of sales, the country is also the hub of research, innovation, and regulation. The US neonatal ventilator marketplace remains highly regulated with FDA recalling faulty products from the market. The dominance of the US in North America’s neonatal ventilator market can be gauged from the fact that it accounts for nearly 83% revenue share of the North American neonatal ventilator market. On the back of strong demand in the US, the North America neonatal ventilator market is likely to reach a valuation of over US$ 163 Mn in 2018.

    Report Analysis@ https://www.factmr.com/report/758/neonatal-ventilator-market 

    Manufacturers can expect a steady stream of opportunities to emerge from developing countries in Asia Pacific, as years of economic growth has led to a strong emphasis on revamping the healthcare system. In terms of revenues, Asia Pacific excluding Japan (APEJ) is likely to maintain its position as the third largest market for neonatal ventilators globally.


    James Hilton
    +353-1-6111-593
    info@factmr.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 15, 2018 ) Global sales of fetal and neonatal heart monitors are likely to surpass 261,000 units in 2018, with rising adoption in the US driving sales. Cardiotocographs remain the highest selling fetal and neonatal heart monitor devices, with global sales equating a valuation of nearly US$ 400 Mn in 2017. Demand continues to remain concentrated in hospitals and neonatal clinics, with the former accounting for a leading share.

    The fetal and neonatal heart monitors continues to be driven by efforts to mitigate the number of preterm births. Data from National Center for Health Statistics shows that the US has a high infant mortality rate among developed economies. The number of deaths per live births also remains a concern in Europe, with governments and healthcare providers in the United Kingdom, France, Germany, and Italy working towards mitigating the numbers.

    The report finds that Asia Pacific excluding Japan (APEJ) will emerge as a lucrative market for fetal and neonatal heart monitor manufacturers during the assessment period. Many countries in the region have high infant mortality rates, and there has been a concerted effort by governments and healthcare providers to improve the situation.

    Click here to subscribe Sample @ https://www.factmr.com/connectus/sample?flag=S&rep_id=750 

    Use of fetal and neonatal heart rate monitors is also growing on account of increase in the number of NICU admissions. The growing applications and deployment of monitoring technologies in NICUs is likely to foster the growth of the fetal and neonatal heart monitor market during the assessment period. The increase in the number of NICUs is also opening opportunities for key players in the market. The report finds that high preterm birth rates in developing countries, such as India has led to opening of new NICUs, which in turn has created opportunities for the deployment of fetal and neonatal heart monitors.

    Although the outlook on the fetal and neonatal heart monitor market remains positive, challenges with performance and false results continue to impede growth. Challenges with wrong heart rate tracking can lead to wrong readings, which in turn can lead to ambiguity. In a bid to address these challenges, manufacturers are focusing on launching innovate and novel products in the market. Philips Avalon has developed smart pulse fetal monitoring technology that uses cross channel verification for ensuring right results. The report opines that manufacturers will continue to focus on research and development to create product differentiation in the market.

    Speak with an Analyst to learn more (methodology) @ https://www.factmr.com/connectus/sample?flag=RM&rep_id=750 

    Fetal and Neonatal Heart Monitors that Detect Metabolic Disorders an Opportunity for Market Participants

    The report finds that market participants have an opportunity of developing fetal and neonatal heart monitors that can diagnose heart rate patterns occurring due to metabolic disorders, such as fetal metabolic acidemia. The fetal and neonatal heart monitors available in the market are not completely successful in detecting metabolic disorders, with many instances going undetected. Manufacturers who are able to launch highly accurate and advanced fetal and neonatal heart monitors in the market can leverage the opportunities emerging in this segment.

    Demand for table top fetal and neonatal heart monitor devices is higher than portable and handheld variants. Hospitals and neonatal clinics around the globe prefer table top devices due to workforce familiarity and cost benefits. The report projects demand for table top devices to be higher than portable and handheld devices over the forecast period.

    Report Analysis@ https://www.factmr.com/report/750/fetal-and-neonatal-heart-monitor-market 


    James Hilton
    +353-1-6111-593
    info@factmr.com

    Source: EmailWire.Com

older | 1 | .... | 1114 | 1115 | (Page 1116) | 1117 | 1118 | .... | 1146 | newer